Kara M L Yannotti

Suggest Changes
Learn More
Fludarabine, cyclophosphamide, and rituximab (FCR) remains the standard of care for fit chronic lymphocytic leukemia (CLL) patients requiring first therapy. However, side effects can be significant,(More)
  • 1